Clinical Trial: WAKE FOREST WF-2201

WAKE FOREST WF-2201

Status: Open

Hypofractionated Radiotherapy vs Single Fraction Radiosurgery for Brain Metastasis Patients on Immunotherapy (HYPOGRYPHE)

Eligible for screening study DCP 001